ARC-Intellicare is a complete platform enabling precision home-based motor rehabilitation to be used after suffering a stroke.
ARC-Intellicare was developed in the framework of the H2020 PCP MAGIC project. In November 2018, CAMLIN will launch the ARCANGEL study, a large and multi-country clinical investigation on stroke survivors, aiming at assessing ARC-Intellicare in the clinical practice. Compared to the current standard of care, with ARC-Intellicare a greater number of patients will benefit from:
Faster access to rehab after discharge.
Safer physical exercise at home.
Longer-term rehab programs, based on real needs.
In November 2018, CAMLIN will launch a first large and multi-country clinical investigation on stroke survivors. The ARCANGEL study will investigate the feasibility and acceptability of introducing ARC-Intellicare in the clinical practice.
PATIENT REPORTED OUTCOMES
DETAILED AUTO REPORTS
CAMLIN is open to collaborations with clinical partners to tailor ARC-Intellicare to the needs of other therapeutic areas, in particular motor neuro-rehabilitation (Parkinson’s and Motor Neuron Diseases) and ortho-rehabilitation (low back pain, post-surgical rehabilitation).